Resources

We aimed to assess the impact of the first lockdown (initiated March 23rd 2020) on methadone- and buprenorphine-related deaths in England in people both prescribed and not prescribed OAT using data

The purpose of the current study is to elicit patients' perspectives on challenges to transition to treatment, including medications for OUD (MOUD), after detox and potential solutions.

Massachusetts is the first state to mandate county jails to deliver all FDA approved medications for opioid use disorder (MOUD).

To identify the association of opioid tapering or abrupt discontinuation with opioid overdose and suicide events among patients receiving stable long-term opioid therapy without evidence of opioid

People who inject drugs are at risk of hospitalisation with injection-related infections (IRI).

This study seeks to examine the provider and organizational factors that could be limiting the treatment of Opioid Use Disorder (OUD) for Black Americans in Texas.

The objective of this study was to compare OUD outcomes among individuals receiving residential and outpatient treatment.

Much of the research on PWUS’ experiences of treatment programs is set in large urban centers creating a knowledge gap of experiences in other places.

The purpose of this study was to explore relations between social and material elements within the acute care environment, to better understand how care is enacted and to identify novel approaches

The aim of this research was to explore family member perspectives on drug consumption rooms (DCR) implementation in Scotland in order to inform national policy.

Synthesize existing research focused on Indigenous Australian peoples' experiences of alcohol and other drug (AOD) treatment.

Our aim was to conduct an in-depth exploration of knowledge and attitudes toward ED naloxone distribution among patients who received a naloxone prescription.

We conducted a systematic review to examine the impacts of drug law enforcement on drug market violence.

In this study, we compared treatment and harm reduction services offered by a multistate sample of substance use service providers and assessed how well they align with characteristics and needs of

We compared the effectiveness of BUP/NX flexible model of care relative to methadone for craving reduction in individuals with prescription-type opioid use disorder (POUD).

This paper examines ‘drug user representation’ in key UN drug policy processes over three decades.

Naloxone distributed to people at risk for opioid overdose has been associated with reduced overdose death rates; however, associations of retail pharmacy-distributed naloxone with overdose mortali